Manufacturer:
Boehringer Ingelheim
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
phone:
855-297-5906 (BI Cares)
Approved Indication:
- treatment of idiopathic pulmonary fibrosis in adults
- treatment of chronic fibrosis interstitial lung diseases with a progressive phenotype in adults
- slowing the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease in adults
Conditions:
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (ILD)